Diabetic retinopathy is a major complication of diabetes recently associated with attenuated photoreceptor function. Multiple stressors in diabetes, such as hyperglycemia, oxidative stress and inflammatory factors, have been identified, but systemic effects of diabetes on outer retina function are incompletely understood. Ex vivo ERG presents the unique opportunity to test rod photoreceptor light signal transduction and transmission and determine whether they are permanently compromised and/or adapt to hyperglycemia in chronic type 2 diabetes. Lightevoked rod photoreceptor signals in control and diabetic mice in vivo were compared to those recorded ex vivo under normal or elevated extracellular glucose. Transduction and transmission of light signals were compromised in 6 mo. diabetic mice in vivo. In contrast, ex vivo rod signaling was similar in isolated retinas from 6 mo. control and diabetic mice under normoglycemic conditions. Acutely elevated glucose ex vivo increased light-evoked photoreceptor responses in control mice, but did not affect light responses in diabetic mice. In summary, our data suggest that long-term diabetes does not irreversibly change the ability of rod photoreceptors to transduce and mediate light signals. However, type 2 diabetes appears to
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Responses to light flashes (rod stimuli, to activate rod phototransduction in rodents), were collected using a ColorDome and Espion V6 software (Diagnosys LLC). response amplitudes were measured between baseline and trough and between trough and peak, respectively and were plotted as the response amplitude over the log light intensity. a-and bwave implicit times were determined as time from stimulus onset to peak. The amplification constant A of phototransduction at 1 cd.s.m -2 was calculated as described by Lamb & Pugh (22) .
To assess dark adaption, rod b-wave sensitivity (S f = b-wave amplitude/Q V ) was initially determined in fully dark-adapted animals averaging 10 light flashes with 10 s inter-flash intervals at 0.25 cd.s.m -2 (S fDA ). Then, bright bleaching light illumination of 1000 cd.m -2 was applied for 30 s, which is predicted to bleach ~90% of rod photopigments. Light stimuli with decreasing Q V ranging from 2 sweeps with a 30 s interval at 50.25 cd.s.m -2 to 10 sweeps with 10 s intervals at 0.25 cd.s.m -2 were applied after the bleach to assess recovery of b-wave S f over 59 min. Sensitivity data are displayed as the S f /S fDA ratio over time.
Ex vivo ERG
Mice were fully dark adapted overnight and sacrificed by CO 2 asphyxia. Eyes were enucleated and dissected in Ames' media supplemented with 0.25 mM sodium glutamate (23) and oxygenated with 95% O 2 /5% CO 2 . The anterior part of the eye and the lens were removed and retinas were carefully dissected and mounted on an ex vivo specimen holder, as previously described (24). Tissue was continuously superfused with oxygenated Ames' media containing 0.25 mM sodium glutamate heated to 36 C. Dissected eye cups from fellow eyes were stored in oxygenated Ames' media at room temperature before used for isolated retina recordings within 2 hours. ERG waveforms were elicited by light stimuli of increasing intensity at a wavelength of 530 nm, amplified using a DP-311 differential amplifier (Warner Systems), digitized with a MEA2100-System (Multichannel Systems), and recorded using Multi Channel Experimenter software. To investigate acute effects of high glucose, we added either 30 mM D-glucose or mannitol as iso-osmotic control to the perfusate in fellow eyes 20 min before recordings were started.
To determine PII responses (originating from ON bipolar cells), combined fast PIII (photoreceptor component) and PII (bipolar cell component) responses were measured at light intensities ranging from 3 to 20 photons μm -2 in the presence of 100 μM BaCl 2 (to inhibit K + channels in Müller glia) (24) . Corresponding fast PIII responses were recorded in the presence of 100 μM BaCl 2 and 40μM DL-AP4 (to block neurotransmission from photoreceptors to ONbipolar cells) and subtracted from combined fast PIII and PII responses to obtain PII responses (25) (Figure 2A -C). Fast PIII response families were recorded at light intensities from 30 to 1,000 photons μm -2 in the presence of 100 μM BaCl 2 and 40 μM DL-AP4. The amplification constant A for phototransduction at a light intensity of 50 photons μm -2 was calculated, as previously described (22) .
Statistical analysis
Data are displayed as arithmetic means ± standard error of the mean. Statistical analysis was performed using Origin software. Differences between two groups with independent values were determined by two-tailed student's t-test, for multiple stimulus intensities by two-way ANOVA.
Data and Resource Availability
No datasets and no applicable resources were generated or analyzed during the current study.
RESULTS

Type 2 diabetes has different effects on outer retinal physiology under in vivo and ex vivo conditions
Long-term diabetes has been shown to impair the function and survival of retinal ganglion and amacrine cells (4; 6; 8; 10; 11), but there is currently no consensus on its effects on phototransduction and synaptic transmission of the rod photoreceptors. Here we first asked: what is the time course of alterations in rod-mediated light signals caused by type 2 diabetes in habitual blood glucose? To answer this question, we compared scotopic in vivo ERG a-and bwaves in db/db mice and their age-matched db/+ controls at 3 and 6 months of age. We used isoflurane anesthesia, which in contrast to ketamine/xylazine anesthesia, did not significantly increase blood glucose in C57BL/6J mice (Supplemental Figure 1C , (26; 27) ).
We did not observe reduced in vivo a-and b-wave amplitudes in diabetic compared to nondiabetic control mice at 3 months of age, but rather a slight increase of the in vivo a-wave amplitude, similar to that reported by Johnson et al. (16) (Figure 1A -C). a-and b-wave implicit times were delayed at this age, suggesting beginning photoreceptor and ON bipolar cell dysfunction ( Figure 1G-H) . Conversely, in 6 month old diabetic mice the scotopic in vivo ERG a-and b-wave amplitudes were reduced ( Figure 1D -F) and a-and b-wave implicit times were delayed ( Figure 1I -J). The amplification constant (A) of phototransduction, a measure of signal amplification in photoreceptors, was determined based on the leading edge of the a-wave, when b-wave intrusion is negligible, as previously described (28). A was not significantly different between 6 month old control and diabetic mice (n=8-9, p=0.25), indicating that the activation reactions of phototransduction in rods are not affected by diabetes. Interestingly, we found a trend towards reduced b/a-wave ratio in diabetic animals compared to non-diabetic controls at 3 months of age, which was highly significant at 6 months of age (Table 1) .
Although in vivo ERG data by us and others suggest that the light-sensitive current and/or synaptic transmission of rods are compromised during long-term hyperglycemia, it is not known whether these changes are related to an altered extracellular environment or permanent molecular/structural changes in rods or rod bipolar cells caused by diabetes. Moreover, systemic effects of anesthesia, such as hyperglycemia, complicate interpretation of the results obtained by in vivo ERG in animal models of diabetes. To determine the effects of chronic diabetes on the intrinsic functional properties of rods and rod bipolar cells in a normoglycemic environment and to avoid systemic complications of anesthesia, we assessed rod phototransduction and synaptic transmission using ex vivo ERG in 6 month old control and diabetic mice. This technique also allowed us to pharmacologically isolate and quantify the fast PIII (rod photoreceptor) and PII (ON bipolar cell) components of the ERG signal (Figure 2A-C) . Surprisingly, in contrast to the in vivo ERG, the amplitudes of the fast PIII or PII components were not significantly changed in 6 month old db/db mice as compared to age-matched db/+ mice ( Figure 2D -E). Contrary to in vivo ERG findings, the ex vivo implicit times of the fast PIII component shortened, with no change seen in the PII time to peak caused by diabetes ( Figure 2H-I However, the PII/fast PIII ratio was not significantly changed between mannitol and glucose supplementation, indicating that the increased PII amplitude in the presence of added glucose derives from the increased photoreceptor responses.
Next, we wanted to know if long-term diabetes alters the acute hyperglycemia-induced augmentation of photoreceptor responses. Diabetes has been shown to cause various long-term adaptations in the retina, including differential expression of glucose transporters (31). Thus, we hypothesized that the photoreceptors in 6 months old db/db mice are less sensitive to elevated extracellular glucose. Indeed, fast PIII amplitudes of db/+ control retinas were significantly augmented in acute hyperglycemia, whereas the photoreceptor responses of db/db retinas were not affected by high glucose exposure ( Figure 5A -C). On the other hand, we did not observe a significant modulation of the PII amplitudes by elevated glucose exposure in control or diabetic mice ( Figure 5D -F), resulting in a reduced PII/fast PIII ratio (data not shown, *p<0.05, n=4-5),
indicative of disrupted signal transmission from photoreceptors to ON-bipolar cells caused by acute hyperglycemia. We observed delayed PIII implicit times in high glucose compared to mannitol iso-osmotic control in both db/+ and db/db retinas ( Figure 5G-I ). While the fast PIII implicit times in db/db retinas were accelerated compared to db/+ retinas in mannitol iso-osmotic control ( Figure 2H ), no significant difference was observed between non-diabetic retinas in normal glucose (with 30 mM mannitol) and diabetic retinas in high glucose ( Figure 5G -H). The amplification constant A as described above was not different between high glucose and mannitol treatment in either db/+ or db/db mice (data not shown), suggesting that the increased implicit times of the rod responses must be due to decelerated phototransduction deactivation rather than activation reactions caused by the elevated glucose. Similar to the PIII times to peak, the PII implicit times lengthened by supplementation with glucose compared to mannitol in both non-diabetic and diabetic animals ( Figure 5I -J). These results indicate that light-evoked potentials of rod photoreceptors from normoglycemic mice can be promoted by acute high glucose treatment. However, long-term diabetes desensitizes photoreceptors to acute hyperglycemia and allows them to maintain normal (lower) light-sensitive current under hyperglycemic environment.
DISCUSSION
It is widely accepted that diabetes results in loss of retinal ganglion and amacrine cells and associated attenuation of oscillatory potentials, both in diabetic animal models and in patients (4; 8; 10; 32). Effects of diabetes on photoreceptor and ON-bipolar cell light signaling remain controversial, however. While many studies demonstrated attenuated a-and b-wave amplitudes of the scotopic in vivo ERG (11; 12; 30; 33) , other reports are contradictory (8; 16; 34). Causes of these discrepancies remain largely unclear, but have previously been ascribed to duration of diabetes (11; 33). This is supported by our study, which shows reduction of in vivo a-and bwave amplitudes in db/db mice at 6 months of age, whereas the scotopic a-wave was increased in 3 months old diabetic mice (Figure 1 D-F and 1 A-C, respectively). Based on our data, we conclude that changes in in vivo rod photoreceptor function are minor at 3 months of age, but significant dysfunction occurs in uncontrolled diabetes (type 2) at 6 months of age. Our data also indicate that signal transmission from rods to rod bipolar cells, measured by the b/a-wave ratio, is impaired in db/db mice, which progresses from 3 to 6 months of age.
Importantly, though, our data imply that altered photoreceptor function in vivo ( Other confounding factors include anesthesia-induced systemic effects. Indeed, anesthetic agents are known to affect ERG amplitudes (40). Thus, one possibility is a different response of retinas in diabetic mice to the systemic changes caused by anesthesia. This is supported by the observation that scotopic a-waves are not altered in conscious human patients with diabetes While photoreceptors are highly metabolically active and mostly depend on glucose as their source of energy (42), effects of acute hyperglycemia on retinal function remain unclear. Studies in patients with diabetes and diabetic animal models suggest a correlation between bipolar cell function and blood glucose levels. In clinical studies the scotopic b-wave amplitude was increased in hyperglycemic diabetes patients (19). Similarly, the scotopic a-and b-waves were reported to be increased in diabetic ZDF rats, while acute insulin treatment resulted in decreased a-wave amplitudes (16). These results seem at odds with our observation that acutely elevated glucose increased photoreceptor responses in control but not in 6 months old db/db mice.
However, in human patients glucose levels are typically controlled by insulin suggesting that the ability to promote photoreceptor responses is lost specifically due to a long-term exposure to an uncontrolled hyperglycemic environment. responses. However, these findings are not universal and increased expression of GLUT-1 in diabetes has also been reported (39). Determining underlying causes for the lack of increased photoreceptor function during acute hyperglycemia in diabetic animals was beyond the scope of this study and should be subject to future investigations.
Effects of long-term diabetes on dark adaptation remain unclear, with subtle deficits reported in diabetic patients (18; 46). Data from diabetic animal models remains controversial, with a recent study showing deficits in rhodopsin regeneration (17) and another demonstrating faster recovery of rod sensitivity after 20% bleach in diabetic rats (30). We demonstrate no change in the recovery kinetics of the rod b-wave sensitivity following ~90% bleach of rhodopsin in 6 month old db/db mice as compared to their age-matched db/+ controls under habitual blood glucose.
This is consistent with a lack of reports of gross dark adaptation deficits in diabetic patients, specifically in comparison to the well documented delayed dark adaptation of the parafoveal rods in AMD patients (47). Indeed, it has been shown that dark adaptation of hyperglycemic diabetic patients is normal, but slowed if blood glucose is lowered to normoglycemic levels (18), which is in agreement with our observation that hyperglycemic db/db mice dark adapt normally.
In summary, we demonstrate that the rods have potential to transduce and transmit light signals normally in db/db mice at least up to 6 month of age under standard ex vivo environment.
Differences between diabetic and non-diabetic mice in the in vivo ERG are likely due to systemic factors, which remain to be identified.
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